Affordable Access

deepdyve-link
Publisher Website

Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.

Authors
  • Scheinberg, Phillip1
  • Wu, Colin O
  • Nunez, Olga
  • Young, Neal S
  • 1 Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Type
Published Article
Journal
The Journal of pediatrics
Publication Date
December 2008
Volume
153
Issue
6
Pages
814–819
Identifiers
DOI: 10.1016/j.jpeds.2008.06.004
PMID: 18672253
Source
Medline
License
Unknown

Abstract

The long-term survival in pediatric patients who respond to IST is excellent, at about 90%. IST remains a good alternative in pediatric patients who lack an HLA-matched sibling donor and should be offered as initial therapy before possible hematopoietic stem cell transplantation from an unrelated donor.

Report this publication

Statistics

Seen <100 times